JPWO2023150767A5 - - Google Patents
Info
- Publication number
- JPWO2023150767A5 JPWO2023150767A5 JP2024546277A JP2024546277A JPWO2023150767A5 JP WO2023150767 A5 JPWO2023150767 A5 JP WO2023150767A5 JP 2024546277 A JP2024546277 A JP 2024546277A JP 2024546277 A JP2024546277 A JP 2024546277A JP WO2023150767 A5 JPWO2023150767 A5 JP WO2023150767A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- subject
- per day
- methyl
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263307506P | 2022-02-07 | 2022-02-07 | |
| US63/307,506 | 2022-02-07 | ||
| US202263382456P | 2022-11-04 | 2022-11-04 | |
| US63/382,456 | 2022-11-04 | ||
| PCT/US2023/062077 WO2023150767A1 (en) | 2022-02-07 | 2023-02-06 | Methods of weight loss and preserving skeletal muscle mass |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025505187A JP2025505187A (ja) | 2025-02-21 |
| JP2025505187A5 JP2025505187A5 (https=) | 2026-02-16 |
| JPWO2023150767A5 true JPWO2023150767A5 (https=) | 2026-02-16 |
Family
ID=85556813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546277A Pending JP2025505187A (ja) | 2022-02-07 | 2023-02-06 | 体重減少の方法および骨格筋量を保存する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250134864A1 (https=) |
| EP (1) | EP4475841A1 (https=) |
| JP (1) | JP2025505187A (https=) |
| KR (1) | KR20240146052A (https=) |
| AU (1) | AU2023216366A1 (https=) |
| CA (1) | CA3243640A1 (https=) |
| CL (1) | CL2024002341A1 (https=) |
| GE (1) | GEAP202416578A (https=) |
| IL (1) | IL314684A (https=) |
| JO (1) | JOP20240177A1 (https=) |
| MX (1) | MX2024009646A (https=) |
| WO (1) | WO2023150767A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025199516A1 (en) * | 2024-03-22 | 2025-09-25 | Board Of Regents, The University Of Texas System | Compositions and methods for preserving or increasing lean muscle mass |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3565806T (pt) | 2017-01-06 | 2022-05-19 | Rivus Pharmaceuticals Inc | Novos derivados de fenilo |
-
2023
- 2023-02-06 GE GEAP202416578A patent/GEAP202416578A/en unknown
- 2023-02-06 IL IL314684A patent/IL314684A/en unknown
- 2023-02-06 US US18/835,559 patent/US20250134864A1/en active Pending
- 2023-02-06 CA CA3243640A patent/CA3243640A1/en active Pending
- 2023-02-06 KR KR1020247029813A patent/KR20240146052A/ko active Pending
- 2023-02-06 EP EP23710157.1A patent/EP4475841A1/en active Pending
- 2023-02-06 JP JP2024546277A patent/JP2025505187A/ja active Pending
- 2023-02-06 AU AU2023216366A patent/AU2023216366A1/en active Pending
- 2023-02-06 WO PCT/US2023/062077 patent/WO2023150767A1/en not_active Ceased
-
2024
- 2024-08-04 JO JOJO/P/2024/0177A patent/JOP20240177A1/ar unknown
- 2024-08-05 MX MX2024009646A patent/MX2024009646A/es unknown
- 2024-08-05 CL CL2024002341A patent/CL2024002341A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Eberhardt et al. | Citicoline in the treatment of Parkinson’s disease | |
| KR20160136451A (ko) | Nafld 및 nash 의 치료 | |
| RU2015110240A (ru) | Ингибиторы nep для лечения заболеваний, характеризующихся увеличением или ремоделированием предсердия | |
| EP2167099A2 (en) | Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine | |
| JP2001509173A (ja) | 胃腸リパーゼ阻害剤の使用 | |
| EP3226873B1 (en) | Compositions comprising 15-hepe and its use for treating or preventing idiopathic pulomonary fibrosis | |
| MX2023004812A (es) | Composiciones de polvo seco de profarmacos de treprostinil y metodos de uso de estos. | |
| US20120083533A1 (en) | Use of amides of mono- and dicarboxylic acids in the treatment of renal diseases | |
| JP4364632B2 (ja) | 糖尿病患者における心室心筋機能を改善するためのアミノ酸を主成分とする組成物 | |
| WO2000054808A1 (fr) | Agoniste du recepteur ep4 de la prostaglandine et traitement correspondant | |
| JPWO2023150767A5 (https=) | ||
| JP2025098147A5 (https=) | ||
| FR2464715A1 (fr) | Utilisation de derives de glycerylphosphoryle dans la therapie des dyslipemies, des hepatites et des etats pathologiques analogues et compositions pharmaceutiques pour cette therapie | |
| WO2018163119A1 (en) | 1-piperidinepropionic acid for treating a fibrosing disease | |
| JPWO2023150759A5 (https=) | ||
| JP4355967B2 (ja) | 医薬組成物 | |
| CN1147765A (zh) | 肺性心病治疗剂 | |
| CN112972440B (zh) | 麝香酮在制备防治抑郁症的药物中的用途 | |
| WO2017126524A1 (ja) | 糖尿病治療剤の併用 | |
| WO2026088203A1 (en) | Synergistic composition for poor muscle health and sarcopenia | |
| JP2003504404A (ja) | 抗虚血薬 | |
| JP2024015394A (ja) | 肥満改善剤 | |
| US4473574A (en) | Prophylaxis of arterial disease | |
| JPWO2022246039A5 (https=) | ||
| US20230141355A1 (en) | Cxcl8 inhibitors for use in the treatment of covid-19 |